1
|
Li W, Berlinicke C, Huang Y, Giera S, McGrath AG, Fang W, Chen C, Takaesu F, Chang X, Duan Y, Kumar D, Chang C, Mao HQ, Sheng G, Dodge JC, Ji H, Madden S, Zack DJ, Chamling X. High-throughput screening for myelination promoting compounds using human stem cell-derived oligodendrocyte progenitor cells. iScience 2023; 26:106156. [PMID: 36852281 PMCID: PMC9958491 DOI: 10.1016/j.isci.2023.106156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Revised: 10/18/2022] [Accepted: 02/03/2023] [Indexed: 02/11/2023] Open
Abstract
Promoting myelination capacity of endogenous oligodendrocyte precursor cells (OPCs) is a promising therapeutic approach for CNS demyelinating disorders such as Multiple Sclerosis (MS). To aid in the discovery of myelination-promoting compounds, we generated a genome-engineered human pluripotent stem cell (hPSC) line that consists of three reporters: identification-and-purification tag, GFP, and secreted-NanoLuc, driven by the endogenous PDGFRA, PLP1, and MBP genes, respectively. Using this cell line, we established a high-throughput drug screening platform and performed a small-molecule screen, which identified at least two myelination-promoting small-molecule (Ro1138452 and SR2211) that target prostacyclin (IP) receptor and retinoic acid receptor-related orphan receptor γ (RORγ), respectively. Single-cell-transcriptomic analysis of differentiating OPCs treated with these molecules further confirmed that they promote oligodendrocyte differentiation and revealed several pathways that are potentially modulated by them. The molecules and their target pathways provide promising targets for the possible development of remyelination-based therapy for MS and other demyelinating disorders.
Collapse
Affiliation(s)
- Weifeng Li
- Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| | - Cynthia Berlinicke
- Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| | - Yinyin Huang
- Sanofi Inc., Translational Science, 350 Water Street, Cambridge, MA, 02141, USA
| | - Stefanie Giera
- Sanofi Inc., Rare and Neurologic Diseases Therapeutic Area, 350 Water Street, Cambridge, MA, 02141, USA
| | - Anna G. McGrath
- Sanofi Inc., Rare and Neurologic Diseases Therapeutic Area, 350 Water Street, Cambridge, MA, 02141, USA
| | - Weixiang Fang
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
| | - Chaoran Chen
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
| | - Felipe Takaesu
- Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine & Georgia Institute of Technology, Atlanta, GA, USA
| | - Xiaoli Chang
- Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| | - Yukan Duan
- Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| | - Dinesh Kumar
- Sanofi Inc., Translational Science, 350 Water Street, Cambridge, MA, 02141, USA
| | - Calvin Chang
- Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
| | - Hai-Quan Mao
- Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
- Institute for NanoBioTechnology, Johns Hopkins University, Whiting School of Engineering Baltimore, MD 21218, USA
| | - Guoqing Sheng
- Sanofi Inc., Rare and Neurologic Diseases Therapeutic Area, 350 Water Street, Cambridge, MA, 02141, USA
| | - James C. Dodge
- Sanofi Inc., Rare and Neurologic Diseases Therapeutic Area, 350 Water Street, Cambridge, MA, 02141, USA
| | - Hongkai Ji
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
| | - Stephen Madden
- Sanofi Inc., Translational Science, 350 Water Street, Cambridge, MA, 02141, USA
| | - Donald J. Zack
- Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
- Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
- The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
- Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| | - Xitiz Chamling
- Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| |
Collapse
|
4
|
Fields RD, Dutta DJ, Belgrad J, Robnett M. Cholinergic signaling in myelination. Glia 2017; 65:687-698. [PMID: 28101995 DOI: 10.1002/glia.23101] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2016] [Revised: 10/26/2016] [Accepted: 11/03/2016] [Indexed: 11/08/2022]
Abstract
There is a long history of research on acetylcholine (ACh) function in myelinating glia, but a resurgence of interest recently as a result of the therapeutic potential of manipulating ACh signaling to promote remyelination, and the broader interest in neurotransmitter signaling in activity-dependent myelination. Myelinating glia express all the major types of muscarinic and nicotinic ACh receptors at different stages of development, and acetylcholinesterase and butyrylcholinesterase are highly expressed in white matter. This review traces the history of research on ACh signaling in Schwann cells, oligodendrocytes, and in the myelin sheath, and summarizes current knowledge on the intracellular signaling and functional consequences of ACh signaling in myelinating glia. Implications of ACh in diseases, such as Alzheimer's disease, multiple sclerosis, and white matter toxicity caused by pesticides are considered, together with an outline of major questions for future research. GLIA 2017;65:687-698.
Collapse
Affiliation(s)
- R Douglas Fields
- Nervous System Development and Plasticity Section, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, Maryland
| | - Dipankar J Dutta
- Nervous System Development and Plasticity Section, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, Maryland.,Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland
| | - Jillian Belgrad
- Nervous System Development and Plasticity Section, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, Maryland
| | - Maya Robnett
- Nervous System Development and Plasticity Section, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, Maryland
| |
Collapse
|
5
|
Hösli L, Hösli E, Zehntner C, Lehmann R, Lutz TW. Evidence for the existence of alpha- and beta-adrenoceptors on cultured glial cells--an electrophysiological study. Neuroscience 1982; 7:2867-72. [PMID: 6296723 DOI: 10.1016/0306-4522(82)90109-9] [Citation(s) in RCA: 79] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
The action of adrenergic alpha- and beta-agonists and antagonists has been studied on the membrane potential and resistance of glial cells of cultured rat central nervous system. Noradrenaline and the alpha-adrenoceptor stimulating agents phenylephrine and clonidine (10(-7) to 10(-4)M) depolarized the glial membrane, whereas the beta-agonist isoprenaline caused a hyperpolarization at low concentrations (10(-7) and 10(-6)M). The effects of noradrenaline and phenylephrine were reversibly blocked by the alpha-antagonist phentolamine, whereas those of isoprenaline were antagonized by the beta-blocker atenolol. Atenolol did not affect the depolarization by noradrenaline. The glial depolarization induced by the alpha-agonists was not the consequence of a change in the extracellular K+-concentration unlike that produced by amino acid transmitters. The present results, together with those of biochemical and autoradiographic binding studies, suggest that alpha- and beta-adrenoceptors occur on glial cells and that the glial depolarization is mediated by alpha-receptors, whereas the hyperpolarization is due to activation of beta-receptors.
Collapse
|
6
|
Hösli E, Hösli L. Evidence for the existence of alpha- and beta-adrenoceptors on neurones and glial cells of cultured rat central nervous system--an autoradiographic study. Neuroscience 1982; 7:2873-81. [PMID: 6296724 DOI: 10.1016/0306-4522(82)90110-5] [Citation(s) in RCA: 57] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
The cellular localization of the binding of radioactive noradrenaline and alpha- and beta-adrenoceptor antagonists was studied in organotypic cultures of rat cerebellum, brain stem and spinal cord using autoradiography. In cerebellar cultures, many neurones, which appeared to be Purkinje cells, were labelled by [3H]noradrenaline and by the beta-antagonists [3H]dihydroalprenolol and [3H]carazolol, whereas no binding of the alpha-antagonists [3H]prazosin and [3H]rauwolscine was detected. In cultures of spinal cord and brain stem, [3H]noradrenaline and the beta-antagonists were bound to many large neurones. Binding of [3H] alpha-antagonists was observed to a small number of brain stem and spinal neurones, the labelling being much weaker than that produced by the [3H] beta-antagonists. The antidepressant [3H]desmethylimipramine was bound to many neurones and glial cells in cerebellar, brain stem and spinal cord cultures. Glial cells also possessed binding sites for [3H]noradrenaline and alpha- and beta-adrenoceptor antagonists, findings that are consistent with recent electrophysiological observations which indicate the existence of alpha- and beta-adrenoceptors on cultured astrocytes.
Collapse
|
22
|
Cho YD, Martin RO, Tunnicliff G. Uptake of (3H)glycine and (14C)glutamate by cultures of chick spinal cord. J Physiol 1973; 235:437-46. [PMID: 4797124 PMCID: PMC1350754 DOI: 10.1113/jphysiol.1973.sp010395] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
1. Spinal cord explants from chick embryos, grown in culture for up to 16 days, rapidly accumulated [(3)H]glycine and [(14)C]glutamate when incubated at 25 degrees C in a medium containing either 2 x 10(-10)M glycine or 4.8 x 10(-8)M glutamate.2. After 90 min incubation, a tissue/medium ratio of 60:1 and 20:1 was attained for [(14)C]glutamate and [(3)H]glycine respectively.3. The uptake systems, in addition to requiring sodium ions in the medium, were temperature sensitive, showed saturation kinetics, and were inhibited by ouabain.4. For the glutamate and glycine accumulation the K(m) value was 4.3 x 10(-5) and 4.1 x 10(-5)M respectively, indicating that a high affinity uptake process is involved.5. The rate of accumulation of both glutamate and glycine increased in cultures between the ages of 3 and 10 days thus matching their morphological development.6. In light of previous evidence, the demonstration of an active transport mechanism for both glutamate and glycine in spinal-cord-cultures that also shows a relationship with morphological maturity, suggests that these two amino acids may play a major role in spinal cord function.
Collapse
|